Ligand Pharmaceuticals (LGND) EV to EBIT (2009 - 2026)

Ligand Pharmaceuticals (LGND) EV to EBIT (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to EBIT
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-1,361.00
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-1.15 Mn
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	6,384.88
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-55,941.43
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-165,640.53
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-152,135.03
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	22.61
9	Abivax	90.15 Bn	90.15 Bn	-	-304.27
10	Ligand Pharmaceuticals	5.07 Bn	4.29 Bn	48.45 Mn	45.36

Download Data